全文获取类型
收费全文 | 942349篇 |
免费 | 68500篇 |
国内免费 | 1456篇 |
专业分类
耳鼻咽喉 | 13048篇 |
儿科学 | 24779篇 |
妇产科学 | 23485篇 |
基础医学 | 134170篇 |
口腔科学 | 28605篇 |
临床医学 | 81202篇 |
内科学 | 186186篇 |
皮肤病学 | 19535篇 |
神经病学 | 73246篇 |
特种医学 | 37312篇 |
外国民族医学 | 79篇 |
外科学 | 154179篇 |
综合类 | 18087篇 |
现状与发展 | 1篇 |
一般理论 | 235篇 |
预防医学 | 61697篇 |
眼科学 | 21510篇 |
药学 | 73514篇 |
3篇 | |
中国医学 | 2141篇 |
肿瘤学 | 59291篇 |
出版年
2018年 | 9352篇 |
2017年 | 7312篇 |
2016年 | 8100篇 |
2015年 | 9245篇 |
2014年 | 12456篇 |
2013年 | 18078篇 |
2012年 | 24945篇 |
2011年 | 26009篇 |
2010年 | 15352篇 |
2009年 | 14724篇 |
2008年 | 25381篇 |
2007年 | 26619篇 |
2006年 | 27349篇 |
2005年 | 26340篇 |
2004年 | 25418篇 |
2003年 | 24339篇 |
2002年 | 23916篇 |
2001年 | 55039篇 |
2000年 | 56766篇 |
1999年 | 47106篇 |
1998年 | 10456篇 |
1997年 | 9110篇 |
1996年 | 9279篇 |
1995年 | 8995篇 |
1994年 | 8362篇 |
1993年 | 7681篇 |
1992年 | 35715篇 |
1991年 | 34144篇 |
1990年 | 32953篇 |
1989年 | 32076篇 |
1988年 | 29159篇 |
1987年 | 28418篇 |
1986年 | 26445篇 |
1985年 | 25298篇 |
1984年 | 17944篇 |
1983年 | 15201篇 |
1982年 | 7835篇 |
1981年 | 6796篇 |
1979年 | 15866篇 |
1978年 | 10657篇 |
1977年 | 9096篇 |
1976年 | 7910篇 |
1975年 | 8684篇 |
1974年 | 10528篇 |
1973年 | 9912篇 |
1972年 | 9415篇 |
1971年 | 8904篇 |
1970年 | 8481篇 |
1969年 | 7979篇 |
1968年 | 7270篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
32.
Stephen T. Russell 《Family relations》2019,68(3):358-370
Given the pace of social changes, meanings of “family” and what makes a family healthy are changing. How can these changing meanings and understandings contribute to social justice for all families? First, I acknowledge how my personal history has intersected with research I do on youth and families. I define social justice with respect to healthy families, and then consider how contemporary scholarship helps define, redefine, and refine what is meant by “family.” Examples are presented from research on cultural influences on parenting; parenting in same‐sex couple or lesbian, gay, bisexual, transgender, or queer (LGBTQ) families; and coming out in adolescence as LGBTQ. These examples illustrate how the notion of family is defined, redefined, and refined to provide new vantage points on the complexities, possibilities, and potential for social justice among contemporary families, especially those that are marginalized. 相似文献
33.
34.
Michael T Milano Veronica L S Chiang Scott G Soltys Tony J C Wang Simon S Lo Alexandria Brackett Seema Nagpal Samuel Chao Amit K Garg Siavash Jabbari Lia M Halasz Melanie Hayden Gephart Jonathan P S Knisely Arjun Sahgal Eric L Chang 《Neuro-oncology》2020,22(12):1728
BackgroundThe American Radium Society (ARS) Appropriate Use Criteria brain malignancies panel systematically reviewed (PRISMA [Preferred Reporting Items for Systematic Reviews and Meta-Analyses]) published literature on neurocognitive outcomes after stereotactic radiosurgery (SRS) for patients with multiple brain metastases (BM) to generate consensus guidelines.MethodsThe panel developed 4 key questions (KQs) to guide systematic review. From 11 614 original articles, 12 were selected. The panel developed model cases addressing KQs and potentially controversial scenarios not addressed in the systematic review (which might inform future ARS projects). Based upon quality of evidence, the panel confidentially voted on treatment options using a 9-point scale of appropriateness.ResultsThe panel agreed that SRS alone is usually appropriate for those with good performance status and 2–10 asymptomatic BM, and usually not appropriate for >20 BM. For 11–15 and 16–20 BM there was (between 2 case variants) agreement that SRS alone may be appropriate or disagreement on the appropriateness of SRS alone. There was no scenario (among 6 case variants) in which conventional whole-brain radiotherapy (WBRT) was considered usually appropriate by most panelists. There were several areas of disagreement, including: hippocampal sparing WBRT for 2–4 asymptomatic BM; WBRT for resected BM amenable to SRS; fractionated versus single-fraction SRS for resected BM, larger targets, and/or brainstem metastases; optimal treatment (WBRT, hippocampal sparing WBRT, SRS alone to all or select lesions) for patients with progressive extracranial disease, poor performance status, and no systemic options.ConclusionsFor patients with 2–10 BM, SRS alone is an appropriate treatment option for well-selected patients with good performance status. Future study is needed for those scenarios in which there was disagreement among panelists. 相似文献
35.
Kerryn W. Reding Aaron K. Aragaki Richard K. Cheng Ana Barac Sylvia Wassertheil-Smoller Jessica Chubak Marian C. Limacher W. Gregory Hundley Ralph D'Agostino Jr. Mara Z. Vitolins Theodore M. Brasky Laurel A. Habel Eric J. Chow Rebecca D. Jackson Chu Chen April Morgenroth Wendy E. Barrington Matthew Banegas Matthew Barnhart Rowan T. Chlebowski 《The oncologist》2020,25(8):712-721
36.
37.
Malinda Itchins Brandon Lau Amanda L. Hudson Helen Westman Cathy Yi Xia Sarah A. Hayes Viive M. Howell Michael Rodriguez Wendy A. Cooper Heng Wei Michael Buckland Bob T. Li Mark Li Vivek Rathi Stephen B. Fox Anthony J. Gill Stephen J. Clarke Michael J. Boyer Nick Pavlakis 《The oncologist》2020,25(8):641-649
38.
39.
M.S. Iqbal G. Vashisht R. McMenemin P. Atherton F. McDonald T. Simmons A. Bradshaw J. Kovarik H. Turnbull L. Dodd P. Mulvenna A. Greystoke 《Clinical oncology (Royal College of Radiologists (Great Britain))》2019,31(2):e1-e10
Aims
Concomitant chemoradiation is the standard of care in patients with inoperable non-small cell lung cancer. The purpose of this study was to analyse the survival outcome and toxicity data of using hypofractionated chemoradiation.Materials and methods
One hundred patients were treated from June 2011 to November 2016. Treatment consisted of 55 Gy in 20 daily fractions concurrently with split-dose cisplatin vinorelbine chemotherapy over 4 weeks followed by two cycles of cisplatin vinorelbine only. Survival was estimated using Kaplan–Meier and Cox regression was carried out for known prognostic factors. A systematic search of literature was conducted using Medline, Embase and Cochrane databases and relevant references included.Results
In total, 97% of patients completed radiotherapy and 73% of patients completed all four cycles of chemotherapy. One patient died of a cardiac event during consolidative chemotherapy. There were two cases of grade 4 toxicities (one sepsis, one renal impairment). Grade 3 toxicities included nausea/vomiting (17%), oesophagitis (15%), infection with neutropenia (12%) and pneumonitis (4%). Clinical benefit was seen in 86%. Two-year progression-free survival and overall survival rates were 49% and 58%, respectively. The median progression-free survival and overall survival were 23.4 and 43.4 months, respectively. The only significant prognostic factor was the number of chemotherapy cycles received (P = 0.02). The systematic review identified 13 relevant studies; a variety of regimens were assessed with variable reporting of outcomes and toxicity but with overall an improvement in survival over time.Conclusion
Our experience compared with the original phase II trial showed improved treatment completion rates and survival with acceptable morbidity. With appropriate patient selection this regimen is an effective treatment option for locally advanced non-small cell lung cancer. This study helps to benchmark efficacy and toxicity rates while considering the addition of new agents to hypofractionated concurrent chemoradiotherapy. The agreement of a standard regimen for assessment in future trials would be beneficial. 相似文献40.
ABSTRACTWhile prior research has demonstrated the benefits of self-affirming individuals prior to exposing them to potentially threatening health messages, the current study assesses the feasibility of inducing self-affirmation vicariously through the success of a character in a narrative. In Study 1, college-age participants who regularly use e-cigarettes (N = 225) were randomly assigned to read one of two versions of a story depicting a college student of their own gender. The versions were identical except in the vicarious self-affirmation (VSA) condition, the main character achieves success (i.e., honored with a prestigious award) before being confronted by a friend about the dangers associated with their e-cigarette use; whereas in the vicarious control condition, the achievement is mentioned after the risk information. Results of the posttest and 10-day follow-up demonstrated that VSA reduced messages derogation, while increasing self-appraisal and perceived risk. The effect of VSA on e-cigarette outcomes was moderated by frequency of use, with heavier users benefiting the most. Study 2 (N = 152) confirmed that traditional value affirmation works with our stimuli on a comparable population. 相似文献